1. European Center for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf . Accessed 4 Apr 2016.
2. European Center for Disease Prevention and Control. Carbapenemase-producing bacteria in Europe. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf . Accessed 4 Apr 2016.
3. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–96.
4. US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf . Accessed 4 Apr 2016.
5. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.